ad image

Platform

1 / 1
Overcoming Challenges to High-Concentration Formulation Development
Formulation

Overcoming Challenges to High-Concentration Formulation Development

Heonchang Lim

Samsung Biologics

PAO-02-25-CL-19Mar 02, 2025
Mitigating Early Development Risks with Samsung Biologics DEVELOPICK™ Platform
Developability

Mitigating Early Development Risks with Samsung Biologics DEVELOPICK™ Platform

Heonchang Lim

Samsung Biologics

PAO-09-24-CL-04Sep 04, 2024
Streamlining the Path to Approval with Developability and Pre-Formulation Platforms
Developability

Streamlining the Path to Approval with Developability and Pre-Formulation Platforms

Andrea Hawe

Coriolis Pharma

PAO-07-24-CL-11Aug 01, 2024
Partnering with Scientific Excellence to De-Risk and Accelerate Drug Development
CRDO

Partnering with Scientific Excellence to De-Risk and Accelerate Drug Development

Silvia Steyrer-Gruber

Coriolis Pharma

PAO-07-24-CL-05Jul 16, 2024
Coriolis Pharma
Monoclonal Antibodies

Coriolis Pharma Launches U.S. Entity Alongside Innovative Drug Product Platform Service Offerings for Monoclonal Antibodies

Coriolis Pharma

PR-05-24-NI-02Jun 18, 2024
1 / 1